Cargando…
Upregulation of C1-inhibitor in pancreatic cancer
PURPOSE: The complement system has recently sparked more interest in cancer research. The classical pathway is initiated by activation of the C1 complex, which irreversibly can be bound to and inhibited by C1-INH. We have previously shown that C1-INH is upregulated in human glioblastoma (astrocytoma...
Autores principales: | Osther, Kurt, Förnvik, Karolina, Liljedahl, Emma, Salford, Leif G., Redebrandt, Henrietta Nittby |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779287/ https://www.ncbi.nlm.nih.gov/pubmed/31620245 http://dx.doi.org/10.18632/oncotarget.27191 |
Ejemplares similares
-
C1-inactivator is upregulated in glioblastoma
por: Förnvik, Karolina, et al.
Publicado: (2017) -
Anti-C1-inactivator treatment of glioblastoma
por: Förnvik, Karolina, et al.
Publicado: (2018) -
Combined anti-C1-INH and radiotherapy against glioblastoma
por: Liljedahl, Emma, et al.
Publicado: (2023) -
Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1
por: Ahlstedt, Jonatan, et al.
Publicado: (2018) -
Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma
por: Liljedahl, Emma, et al.
Publicado: (2022)